DCRI Cardiologists Help to Define Care Pathway for Patients with COVID-19
In response to a wide array of cardiovascular complications seen in patients with COVID-19, the Duke Health system has developed a framework which organizes its approach to caring for patients with
DCRI to Partner with Boehringer Ingelheim and Eli Lilly on new Pragmatic Trial
The indication-seeking trial is the first in the SGLT2 inhibitor class to investigate whether empagliflozin can be used to prevent heart failure after a heart attack.
IPF-PRO Registry Continues to Shed Light on Devastating Lung Disease
The registry, which has enrolled 1,002 patients with idiopathic pulmonary fibrosis, shares critical knowledge and insights to help combat lung disease.
Pediatric Trials Network Research Contributes to Three Recent Drug Label Changes
Data provided to the FDA by the research network has helped to provide a fuller picture for prescribing these medications to pediatric populations.
Novel Micra Pacemaker Found to Reduce Patient Risk
A pragmatic comparative effectiveness study comparing Micra leadless pacemakers to conventional transvenous pacemakers found that for patients who received the novel leadless pacemakers, complicati
DCRI Welcomes New Executive Director
A cardiologist and internationally recognized clinical research expert will become the Institute’s new leader.
PTN to Study Pediatric Dosing for Potential COVID-19 Drugs
Major Reform Needed to Enable a Learning Health System to Generate Evidence
A paper authored by the DCRI’s Adrian Hernandez, MD, MHS, and colleagues calls for major changes in the research ecosystem to enable pragmatic trials, especially those comparing different treatment
DCRI, Bayer Partner to Tackle Three Cardiovascular Conditions